We are very pleased to announce that the webinar “SMA Treatment: Latest Update”, jointly organized by Families of SMA (Spinal Muscular...

很高興與大家分享一則喜訊，美國食品藥物管理局(簡稱FDA)正式批准治療SMA的新藥Evrysdi (risdiplam) 面世 ! 跟Spinraza不一様， 由Roche 藥廠研製，新藥是口服治療，針對兩個月大以上的嬰兒及成年人患者。有關新藥詳情大家可以留意藥廠發出的新聞...